C

Compass Pathways

Develops psilocybin-based therapies for TRD

Manager – Revenue Accounting

Financial AccountingUpdated on Nov 11
Full-timeNortheastern United States, USA

About the Job

Requirements

  • A bachelor's degree in Accounting, Finance, or a related field is required; a CPA or equivalent professional accounting qualification is strongly preferred.
  • Approximately 7 or more years of relevant accounting experience, with flexibility depending on the level of the successful candidate.
  • Strong technical knowledge of U.S. GAAP, particularly ASC 606, with demonstrated experience applying revenue recognition guidance to commercial arrangements and variable consideration.
  • Hands-on experience with U.S. pharmaceutical or biopharmaceutical product revenue accounting, including gross-to-net accounting and related reconciliations and controls.
  • Experience supporting quarterly and annual financial reporting and external audits, with hands-on experience owning and operating SOX controls and preparing supporting documentation in a public company environment.
  • Strong analytical skills and the ability to develop and document significant accounting estimates and translate complex commercial arrangements into clear accounting conclusions and operational processes.
  • Demonstrated ability to work independently, build new processes, partner effectively with Finance and non-Finance stakeholders, and communicate technical accounting matters clearly.
  • Demonstrates Compass values.

Responsibilities

  • Lead the development and implementation of scalable revenue accounting processes, policies, and controls in preparation for potential U.S. commercialization.
  • Own accounting assessments of commercial arrangements under ASC 606, including customer contract reviews and documentation of significant accounting judgments.
  • Develop and maintain the Company's gross-to-net accounting framework, including methodologies for estimating and recording applicable commercial and governmental rebates, discounts, chargebacks, distribution fees, returns, and other deductions from gross revenue; coordinate sourcing, validation, and processing of data used in gross-to-net estimates and accruals.
  • Partner with Commercial Operations, Market Access, Legal, and Supply Chain to evaluate proposed pricing, contracting, distribution, specialty pharmacy, and other commercial arrangements and identify accounting, data, and control implications.
  • Establish accounting processes for product sales through relevant distribution and pharmacy channels, including revenue recognition, inventory movement, reconciliation of channel data, customer payment terms, and accounts receivable, in partnership with the 3PL and/or other operational process owners.
  • Lead the revenue accounting workstream, identify accounting, systems, data, and control requirements associated with the first potential product launch, and help drive cross-functional launch-readiness activities.
  • Own or oversee monthly and quarterly revenue accounting activities, including journal entries, account reconciliations, gross-to-net accruals, and related account analyses.
  • Develop and maintain revenue-related accounting policies, technical accounting memos, and audit-ready documentation supporting significant estimates, judgments, and changes in assumptions, including methodologies, data, and controls supporting gross-to-net reserves.
  • Establish processes for timely Finance review of new or modified commercial agreements, including identification of revenue recognition, gross-to-net, systems, and internal control implications before execution.
  • Establish and maintain SOX-compliant controls over revenue, gross-to-net estimates, accounts receivable, and related commercial processes, including preparation and retention of complete, audit-ready control evidence.
  • Develop processes to compare actual gross-to-net activity with recorded estimates, analyze variances, and refine assumptions as commercial experience develops.
  • Support financial statement disclosures and management reporting related to revenue and associated balance sheet accounts.
  • Partner with external auditors and advisors on revenue accounting matters and provide supporting documentation for quarterly reviews, annual audits, and control testing.
  • Partner with Finance Operations, IT, and Commercial Operations to define the systems, master data, interfaces, and reporting required to support the order-to-cash process.
  • Establish processes to capture and reconcile data received from distributors, specialty pharmacies, third-party logistics providers, and other commercial partners.
  • Work with FP&A to support revenue and gross-to-net forecasting, assess accounting assumptions, and explain actual-to-forecast variances.
  • Collaborate with Supply Chain on the interaction between revenue recognition, inventory, and cost of goods sold, including relevant transfer-of-control considerations.
  • Identify opportunities to automate revenue accounting processes, improve data integrity, and strengthen controls as commercial transaction volumes increase.

Desired Qualifications

  • Experience preparing a biotechnology or pharmaceutical company for its first commercial product launch.
  • Knowledge of pharmaceutical gross-to-net arrangements, including payer rebates, government programs, chargebacks, returns, discounts, and distribution-related fees, and experience accounting for and reconciling government and commercial rebate activity.
  • Experience with specialty pharmacy, specialty distribution, and/or third-party logistics models.
  • Experience implementing or enhancing ERP, revenue, gross-to-net, or other commercial accounting systems.
  • Public accounting and SEC reporting experience.

About the Company

Compass Pathways

Develops psilocybin-based therapies for TRD

COMPASS Pathways develops psilocybin-based therapies for mental health, focusing on treating treatment-resistant depression (TRD). Its lead drug candidate, COMP360, is a high-purity psilocybin formulation given alongside psychological support from trained therapists. The treatment is delivered through a global Phase 3 program, aiming to establish a regulatory-approved therapy. Compared with other players, COMPASS emphasizes a standardized therapeutic model that pairs a pharmaceutical compound with guided psychotherapy and has the largest psilocybin Phase 3 program to date, supported by Breakthrough Therapy designation from the FDA. The company originated from a nonprofit idea, transformed into a for-profit entity to fund extensive trials, and is pursuing regulatory approval and eventual commercialization through licensing and partnerships. Its goal is to bring approved, evidence-based psilocybin treatments to patients with TRD and scale access through a commercial pathway.

Company size
201-500
Company stage
IPO
Headquarters
London, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at Compass Pathways

See more jobs